Login / Signup

Thyroid Medication Use and Birth Defects in the National Birth Defects Prevention Study.

Meredith M HowleySarah C FisherAlissa R Van ZutphenDorothy K WallerSuzan L CarmichaelMarilyn L Brownenull null
Published in: Birth defects research (2017)
While new associations were identified, our findings are relatively consistent with previous NBDPS analyses. Our findings suggest thyroid medication use is not associated with most birth defects studied in the NBDPS, but may be associated with some specific birth defects. These results should not be interpreted to suggest that medications used to treat thyroid disease are teratogens, as the observed associations may reflect effects of the underlying thyroid disease. Birth Defects Research 109:1471-1481, 2017.© 2017 Wiley Periodicals, Inc.
Keyphrases
  • gestational age
  • pregnancy outcomes
  • pregnant women